- No products in the cart.
SYSTAAQ History
SYSTAAQ is a USA based firm. The company was founded in 2012 with the intention of making custom nucleic acid tests more widely available, enabling the widespread usage of molecular diagnostics with potential to benefit society.
SYSTAAQ has some of the most capable scientists in the world with extensive experience in the respective field. SYSTAAQ has capabilities to develop new tests in less than 30 days.
Following this tradition, the SYSTAAQ team is actively developing and commercializing new molecular diagnostic assays – fast, flexible, reliable and close to the customer needs. SYSTAAQ produces a growing portfolio of tests for infectious diseases such as HIV, Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis D (HDV), Cytomegalovirus (CMV), M. tuberculosis complex and Dengue.